NCT00646984View on ClinicalTrials.gov

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

PHASE4CompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2006

Conditions
HIV-Associated Lipodystrophy Syndrome
Interventions
DRUG

Standard continuous antiretroviral therapy

DRUG

CD-4 guided therapy interruption

Stop antiretroviral therapy when CD-4 equal or above 350 and reinitiate when below 350

DRUG

Viral load driven treatment interruption

Stop antiretroviral therapy when viral load below 30,000 copies/ml and reinitiate when equal or above 30,000 copies/ml

Trial Locations (1)

08036

Hospital Clinic of Barcelona, Barcelona

All Listed Sponsors
lead

Hospital Clinic of Barcelona

OTHER

NCT00646984 - Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy | Biotech Hunter | Biotech Hunter